Purple Biotech Ltd Working Capital to Net Assets Ratio
Purple Biotech Ltd working capital to net assets ratio. Purple Biotech Ltd (KTOV) has a Working Capital to Net Assets ratio of 63.7% as of June 2020. Working capital of ILA35.78 Million (current assets of ILA65.16 Million minus current liabilities of ILA29.38 Million) is measured against net assets of ILA56.15 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Purple Biotech Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Purple Biotech Ltd (2013–2019)
Working capital to net assets ratio of Purple Biotech Ltd from 2013 to 2019. This chart shows how Purple Biotech Ltd's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2013 to 2019. As of June 2020, the ratio stands at 63.7%, reflecting working capital of ILA35.78 Million against net assets of ILA56.15 Million ILA. See defensive interval ratio of Purple Biotech Ltd to measure how many days the company can operate on defensive assets alone.
Purple Biotech Ltd Working Capital to Net Assets Ratio by Year (2013–2019)
Purple Biotech Ltd working capital to net assets ratio by year from 2013 to 2019. The table below presents the year-by-year Working Capital to Net Assets ratio for Purple Biotech Ltd from 2013 to 2019, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see KTOV current and non-current assets.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 43.8% | ILA4.76 Million | ILA10.86 Million | ILA8.30 Million | ILA3.55 Million | ▼ -3.5 pp |
| 2018 | 47.3% | ILA5.20 Million | ILA11.00 Million | ILA8.51 Million | ILA3.31 Million | ▲ +0.6 pp |
| 2017 | 46.7% | ILA4.01 Million | ILA8.59 Million | ILA7.98 Million | ILA3.97 Million | ▼ -55.1 pp |
| 2016 | 101.8% | ILA13.62 Million | ILA13.38 Million | ILA14.90 Million | ILA1.27 Million | ▼ -0.1 pp |
| 2015 | 101.9% | ILA9.61 Million | ILA9.43 Million | ILA10.80 Million | ILA1.20 Million | ▲ +1.9 pp |
| 2014 | 100.0% | ILA851.00K | ILA851.00K | ILA1.76 Million | ILA908.00K | ▲ +0.0 pp |
| 2013 | 100.0% | ILA-946.00K | ILA-946.00K | ILA311.00K | ILA1.26 Million | — |